Cleveland Diagnostics
In Brief This Week: Quest Diagnostics, Ginkgo Bioworks, Novacyt, Danaher, and More
News items for the in vitro diagnostics industry for the week of May 3, 2021.
Cleveland Diagnostics Raises $19.4M
The company said the funding would be used to further commercialize its IsoPSA blood-based prostate-specific antigen assay and to develop tests for other cancers.